Sintx (SINT) Revenue & Revenue Breakdown
Sintx Revenue Highlights
Latest Revenue (Y)
$2.63M
Latest Revenue (Q)
$799.00K
Sintx Revenue by Period
Sintx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.63M | 337.10% |
| 2022-12-31 | $601.00K | -0.83% |
| 2021-12-31 | $606.00K | 2.02% |
| 2020-12-31 | $594.00K | -13.79% |
| 2019-12-31 | $689.00K | 625.26% |
| 2018-12-31 | $95.00K | -99.15% |
| 2017-12-31 | $11.23M | -26.26% |
| 2016-12-31 | $15.23M | -21.73% |
| 2015-12-31 | $19.45M | -14.55% |
| 2014-12-31 | $22.77M | 2.02% |
| 2013-12-31 | $22.31M | -3.26% |
| 2012-12-31 | $23.07M | 13.84% |
| 2011-12-31 | $20.26M | - |
Sintx generated $2.63M in revenue during NA 2023, up 337.10% compared to the previous quarter, and up 2765.26% compared to the same period a year ago.
Sintx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $799.00K | -6.98% |
| 2024-06-30 | $859.00K | 25.04% |
| 2024-03-31 | $687.00K | -23.84% |
| 2023-12-31 | $902.00K | 33.04% |
| 2023-09-30 | $678.00K | 188.51% |
| 2023-06-30 | $235.00K | -2.08% |
| 2023-03-31 | $240.00K | -2.83% |
| 2022-12-31 | $247.00K | 42.77% |
| 2022-09-30 | $173.00K | 116.25% |
| 2022-06-30 | $80.00K | -20.79% |
| 2022-03-31 | $101.00K | -38.79% |
| 2021-12-31 | $165.00K | -30.96% |
| 2021-09-30 | $239.00K | 136.63% |
| 2021-06-30 | $101.00K | - |
| 2021-03-31 | $101.00K | -12.93% |
| 2020-12-31 | $116.00K | 75.76% |
| 2020-09-30 | $66.00K | -67.65% |
| 2020-06-30 | $204.00K | -1.45% |
| 2020-03-31 | $207.00K | -17.86% |
| 2019-12-31 | $252.00K | 45.66% |
| 2019-09-30 | $173.00K | 3.59% |
| 2019-06-30 | $167.00K | 72.16% |
| 2019-03-31 | $97.00K | 2.11% |
| 2018-12-31 | $95.00K | 100.00% |
| 2018-09-30 | - | -100.00% |
| 2018-06-30 | $2.04M | -11.00% |
| 2018-03-31 | $2.29M | -5.88% |
| 2017-12-31 | $2.43M | -17.66% |
| 2017-09-30 | $2.96M | -7.86% |
| 2017-06-30 | $3.21M | 22.02% |
| 2017-03-31 | $2.63M | -28.01% |
| 2016-12-31 | $3.65M | 8.11% |
| 2016-09-30 | $3.38M | -16.03% |
| 2016-06-30 | $4.02M | -3.59% |
| 2016-03-31 | $4.17M | -18.10% |
| 2015-12-31 | $5.09M | 5.38% |
| 2015-09-30 | $4.83M | 1.15% |
| 2015-06-30 | $4.78M | 0.78% |
| 2015-03-31 | $4.74M | -7.92% |
| 2014-12-31 | $5.15M | -14.12% |
| 2014-09-30 | $6.00M | 2.78% |
| 2014-06-30 | $5.84M | 0.97% |
| 2014-03-31 | $5.78M | 1.22% |
| 2013-12-31 | $5.71M | 7.78% |
| 2013-09-30 | $5.30M | -12.47% |
| 2013-06-30 | $6.05M | 15.23% |
| 2013-03-31 | $5.25M | -11.55% |
| 2012-12-31 | $5.94M | 4.10% |
| 2012-09-30 | $5.70M | - |
Sintx generated $799.00K in revenue during Q3 2024, up -6.98% compared to the previous quarter, and up 340.00% compared to the same period a year ago.
Sintx Revenue Breakdown
Sintx Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 |
|---|---|---|---|
| Grant and Contract | $432.00K | $481.00K | - |
| Product | $367.00K | $378.00K | $309.00K |
| Grant And Contract | - | - | $378.00K |
Latest
Sintx's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant and Contract (54.07%), and Product (45.93%).
Sintx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IRIX | IRIDEX | $51.87M | $11.58M |
| NUWE | Nuwellis | $8.86M | $2.37M |
| RSLS | ReShape Lifesciences | $8.68M | $2.29M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| SINT | Sintx | $2.63M | $799.00K |
| NAOV | NanoVibronix | $2.28M | $376.00K |
| TIVC | Tivic Health Systems | $1.18M | $126.00K |
| HSDT | Helius Medical | $644.00K | $51.00K |
| MOTS | Motus GI | $319.00K | $64.00K |
| NXL | Nexalin | $110.75K | $36.03K |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |